Finance

Lists
XPER:NYSE
Xperi Inc
USD 5,17
-0,77%
(-0,040) 1D
23 Okt., 10:01:40 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XPER...
Open
USD 5,18
High
USD 5,22
Low
USD 5,09
Mkt. cap
252,15 m
Avg. vol.
388,94 k
Volume
7,00 k
52-wk high
USD 26,00
52-wk low
USD 5,09
EPS
-USD 0,70
Beta
0,90
Shares outstanding
48,77 m
No. of employees
1 k
Open
USD 5,18
High
USD 5,22
Low
USD 5,09
Mkt. cap
252,15 m
Avg. vol.
388,94 k
Volume
7,00 k
52-wk high
USD 26,00
52-wk low
USD 5,09
EPS
-USD 0,70
Beta
0,90
Shares outstanding
48,77 m
No. of employees
1 k
News stories
From web sources and news partners
About Xperi Inc
CEO-
Employees1,38 k
Founded2019
HeadquartersSan Jose, Kalifornië, Verenigde State van Amerika
Sector-
Websitexperi.com
Analyst ratings
Based on 4 analysts giving stock ratings to XPER in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for XPER in the last 3 months.
Highest
Current USD 5,17
USD 13,00 (+151,45%)
Average
USD 11,25 (+117,60%)
Lowest
USD 10,00 (+93,42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Hamed Khorsand
BWS Financial
Buy
Maintained
USD 12,00
+132,1%
08/07/2026
Matthew Galinko
Maxim Group
Buy
Maintained
USD 13,00
+151,5%
08/07/2026
Steve Frankel
Rosenblatt Securities
Buy
Maintained
USD 10,00
+93,4%
08/06/2026
Jason Kreyer
Craig-Hallum
Buy
Maintained
USD 10,00
+93,4%
08/06/2026
Unknown Analyst
Rosenblatt Securities
Buy
Maintained
USD 10,00
+93,4%
05/06/2026
Next call oor 12 dae
Do. 5 Nov., 00:00
Fiscal period
Q3 2026
- / USD 0,17
Revenue / Est. (USD)
- / 111,47 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
111,63 m
116,51 m
114,21 m
114,49 m
Cost of goods sold
29,08 m
32,12 m
30,88 m
36,07 m
Cost of revenue
29,08 m
32,12 m
30,88 m
36,07 m
Research and development expenses
29,92 m
27,85 m
27,08 m
21,81 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,54 m
45,86 m
41,79 m
41,46 m
Operating expense
83,92 m
85,30 m
81,18 m
75,31 m
Total operating expenses
112,99 m
117,42 m
112,06 m
111,38 m
Operating income
-1,36 m
-908,00 k
2,15 m
3,11 m
Other non operating income
-
-
-
-
EBT including unusual items
-1,30 m
-14,29 m
2,29 m
3,33 m
EBT excluding unusual items
-1,30 m
-405,00 k
2,29 m
3,52 m
Income tax expense
4,80 m
2,79 m
10,12 m
4,83 m
Effective tax rate
-369,05%
-19,53%
441,45%
145,10%
Other operating expenses
-
-
-
-
Net income
-6,11 m
-17,08 m
-7,83 m
-1,50 m
Net profit margin
-5,47%
-14,66%
-6,85%
-1,31%
Earnings per share
0,28
0,24
0,23
0,28
Interest and investment income
821,00 k
1,23 m
819,00 k
1,10 m
Interest expense
-761,00 k
-727,00 k
-678,00 k
-684,00 k
Net interest expenses
60,00 k
503,00 k
141,00 k
413,00 k
Depreciation and amortization charges
3,47 m
3,60 m
4,26 m
3,95 m
EBITDA
13,34 m
3,44 m
11,62 m
12,59 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme